Center for Scientific Review; Notice of Closed Meetings, 58144-58145 [2012-23131]
Download as PDF
<![CDATA[
58144
Federal Register / Vol. 77, No. 182 / Wednesday, September 19, 2012 / Notices
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Marsha A. Jones, Office of Antimicrobial
Resistance, Centers for Disease Control
and Prevention, 1600 Clifton Road, NE.,
Mailstop C–12, Atlanta, GA 30333;
telephone 404–639–4111; Email
MJones@cdc.gov.
Registration and Special
Accommodations: Persons wishing to
participate or who need special
accommodations or both must register at
ARplancomments@cdc.gov or by
contacting Marsha Jones at
MJones@cdc.gov. See Registration to
Attend or Participate in the Public
Meeting for instructions on how to
submit electronic notices of
participation.
SUPPLEMENTARY INFORMATION:
tkelley on DSK3SPTVN1PROD with NOTICES
1. Background
The Interagency Task Force on
Antimicrobial Resistance (ITFAR) was
created in 1999 in recognition of the
increasing importance of antimicrobial
resistance (AR) as a public health threat.
The ITFAR coordinates the activities of
federal agencies in addressing
antimicrobial resistance (AR) and is cochaired by HHS/CDC, HHS/FDA, and
HHS/NIH. Other HHS Task Force
members include the Agency for
Healthcare Research and Quality
(AHRQ), the Centers for Medicare and
Medicaid Services (CMS), the Health
Resources and Services Administration
(HRSA), and the HHS Office of the
Assistant Secretary of Health (HHS/
OASH). Non-HHS Task Force members
include the Department of Agriculture
(USDA), the Department of Defense
(DoD), the Department of Veterans
Affairs (VA), and the Environmental
Protection Agency (EPA).
In 2001, the ITFAR developed an
initial Action Plan to combat AR. This
Plan, titled ‘‘A Public Health Action
Plan to Combat Antimicrobial
Resistance’’, outlined specific goals,
actions, and implementation steps
important for addressing the problem of
antimicrobial resistance. Action items
were organized into four focus areas:
Surveillance, Prevention and Control,
Research, and Product Development.
The Action Plan and Annual Report are
available at www.regulations.gov docket
number CDC–2012–0011. In 2012, a
revised version of the Action Plan
addressing the evolving threat of
antimicrobial resistance was published.
These background documents are also
included in the docket.
VerDate Mar<15>2010
19:20 Sep 18, 2012
Jkt 226001
2. Public Comment and Meeting
The public meeting process provides
an opportunity for the public to
comment on the activities of the ITFAR
to date. In addition, the ITFAR invites
written comments or oral presentations
by interested persons on the Annual
Report as well as the four focus areas of
the Action Plan: Surveillance,
Prevention and Control, Research, and
Product Development. Written
comments should be submitted
following the instructions provided in
ADDRESSES.
Comments and suggestions from the
public on the Annual Report or any of
the focus areas of the Action Plan will
be reviewed and carefully considered by
the ITFAR. The public should be aware
that this meeting agenda does not
include development of consensus
positions, guidelines, interrogatories, or
discussions or endorsement of specific
commercial products.
3. Registration To Attend or Participate
in the Public Meeting
Participants are asked to preregister to
ensure sufficient space. Seating capacity
is limited to 200 persons. Those wishing
to make an oral presentation during the
open public comment period of the
hearing should state your intention to
present on your registration submission.
To register, please send an electronic
mail message to
ARplancomments@cdc.gov by 12 p.m.
EDT, Thursday, October 25, 2012. Your
email should include your name, email
address, and a written statement
identifying each focus area you wish to
address and the approximate time
requested to make your presentation.
Organizations should provide this
information as well as the names and
email addresses of all participants.
Because of time restrictions, the number
of presenters will be limited to the first
12 to 15 registrants submitting requests
to make presentations. The final number
of presenters will be determined by the
approximate time requested by each
presenter. If the number and time
requested for presentations exceed the
time allotted for public comment, the
length of presentations may be limited;
registered presenters will be notified of
the approximate time scheduled for
their presentation prior to the meeting.
All other comments may be submitted
in writing following the instructions
listed in ADDRESSES.
4. Building and Security Guidelines
The Hubert H. Humphrey Building is
the headquarters of the U.S. Department
of Health and Human Services and is
located at the foot of Capitol Hill at 200
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Independence Avenue SW.,
Washington, DC 20201. The Humphrey
Building is served by Metrorail and
Metrobus. The closest Metrorail station
is the Federal Center SW station, which
is served by the Blue and Orange lines.
The meeting is being held in a Federal
government building; therefore, Federal
security measures are applicable. In
planning your arrival, please take
account of the need to clear security. All
visitors must enter through the HHS
Hubert H. Humphrey Building main
entrance and present government-issued
photo identification (e.g., a valid
Federal identification badge, state
driver’s license, state non-driver’s
license, or passport).
All persons entering the building
must pass through a metal detector.
Visitors are issued a visitor’s ID
wristband in the main lobby and are
escorted in groups of five to the meeting
room. All items brought to HHS are
subject to inspection.
Dated: September 13, 2012.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2012–23041 Filed 9–18–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR11–145:
International Research in Infectious Diseases
including AIDS (IRIDA).
Date: October 10, 2012.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites DC Convention
Center, 900 10th Street NW., Washington, DC
20001.
E:\FR\FM\19SEN1.SGM
19SEN1
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 182 / Wednesday, September 19, 2012 / Notices
Contact Person: Soheyla Saadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3211,
MSC 7808, Bethesda, MD 20892, 301–435–
0903 saadisoh@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Biomarkers Study Section.
Date: October 15–16, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–357–
9318, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer
Therapeutics AREA Grant Applications.
Date: October 15, 2012.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Denise R Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Topics in Bacterial Pathogenesis.
Date: October 18–19, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: Rolf Menzel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
MSC 7808, Bethesda, MD 20892, 301–435–
0952, menzelro@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Drug Discovery for the
Nervous System Study Section.
Date: October 18–19, 2012.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue NW., Washington, DC 20037.
Contact Person: Mary Custer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7850, Bethesda, MD 20892, (301) 435–
1164, custerm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: Mechanisms of Cilium-Based
Signaling.
Date: October 18–19, 2012.
Time: 11 a.m. to 5 p.m.
VerDate Mar<15>2010
19:20 Sep 18, 2012
Jkt 226001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: T Cell Activation & Regulation of
Programmed Necrosis by Caspase-8.
Date: October 18, 2012.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Bahiru Gametchu, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–435–
1225, gametchb@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Biostatistical Methods and Research Design
Study Section.
Date: October 19, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Inner Harbor, 301 W.
Lombard St., Baltimore, MD 21201.
Contact Person: Tomas Drgon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3152,
MSC 7770, Bethesda, MD 20892, 301–435–
1017, tdrgon@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Molecular Probes.
Date: October 19, 2012.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW., Washington, DC 20037.
Contact Person: Mary Custer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7850, Bethesda, MD 20892, (301) 435–
1164, custerm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 11–
045: Outcome Measures For Use In
Treatment Trials For Individuals with
Intellectual and Developmental Disabilities
(R01).
Date: October 19, 2012.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Chicago Downtown/River
North, 30 East Hubbard, Chicago, IL 60611.
Contact Person: Jane A DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
58145
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 13, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–23131 Filed 9–18–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee on Research on
Women’s Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: October 15–16, 2012.
Time: 1 p.m. to 5 p.m.
Agenda: The purpose of the meeting will
be for the Committee to provide advice to the
Office of Research on Women’s Health
(ORWH) on appropriate research activities
with respect to women’s health and related
studies to be undertaken by the national
research institutes; to provide
recommendations regarding ORWH
activities; to meet the mandates of the office;
and for discussion of scientific issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Joyce Rudick, Director,
Programs & Management, Office of Research
on Women’s Health, Office of the Director,
National Institutes of Health, Building 1,
Room 201, Bethesda, MD 20892, 301/402–
1770.
Information is also available on the
Meeting registration Web site: https://
palladianpartners.cvent.com/
ACRWHFall2012 where any additional
information for the meeting will be posted
when available.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
E:\FR\FM\19SEN1.SGM
19SEN1
]]>Agencies
[Federal Register Volume 77, Number 182 (Wednesday, September 19, 2012)]
[Notices]
[Pages 58144-58145]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-23131]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR11-145: International Research in Infectious Diseases
including AIDS (IRIDA).
Date: October 10, 2012.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites DC Convention Center, 900 10th Street NW.,
Washington, DC 20001.
[[Page 58145]]
Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
0903 saadisoh@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Biomarkers Study Section.
Date: October 15-16, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, 301-357-9318, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cancer Therapeutics AREA Grant Applications.
Date: October 15, 2012.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Denise R Shaw, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD 20892, 301-435-
0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Topics: Topics in Bacterial Pathogenesis.
Date: October 18-19, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Rolf Menzel, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301-435-
0952, menzelro@csr.nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Drug Discovery for the Nervous
System Study Section.
Date: October 18-19, 2012.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Avenue NW., Washington,
DC 20037.
Contact Person: Mary Custer, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435-
1164, custerm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Program Project: Mechanisms of Cilium-Based Signaling.
Date: October 18-19, 2012.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: T Cell Activation & Regulation of Programmed
Necrosis by Caspase-8.
Date: October 18, 2012.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Bahiru Gametchu, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204, MSC 7812, Bethesda, MD
20892, 301-435-1225, gametchb@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Biostatistical Methods and Research Design
Study Section.
Date: October 19, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Inner Harbor, 301 W. Lombard St., Baltimore,
MD 21201.
Contact Person: Tomas Drgon, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3152, MSC 7770, Bethesda, MD 20892, 301-435-
1017, tdrgon@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Molecular Probes.
Date: October 19, 2012.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Ave. NW., Washington, DC
20037.
Contact Person: Mary Custer, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435-
1164, custerm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 11-045: Outcome Measures For Use In Treatment Trials For
Individuals with Intellectual and Developmental Disabilities (R01).
Date: October 19, 2012.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Chicago Downtown/River North, 30 East Hubbard,
Chicago, IL 60611.
Contact Person: Jane A Doussard-Roosevelt, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435-4445, doussarj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 13, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-23131 Filed 9-18-12; 8:45 am]
BILLING CODE 4140-01-P
